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ABSTRACT
Objective: Diabetes, the “third killer” of mankind, is now a global burden affecting nearly 10% of the population. The present study aimed at 
pharmacognostical evaluation of Syzygium cumini seed powder, phytochemical profiling, total phenolic, and flavonoid content determination and to 
ascertain its antioxidant activity and hypoglycemic potential in alloxan-induced diabetic rats.
Methods: Pharmacognostical and physicochemical parameters of the seed powder were determined by using standard methods as per Ayurvedic 
Pharmacopoeia of India (API). In vitro antioxidant activity was determined by 1, 1-diphenyl-2-picrylhydrazyl (DPPH) radical scavenging 
activity. Ethanolic extract of Syzygium cumini seed at a dose of 200mg/kg and 400mg/kg body weight (bw) were given orally in alloxan-induced 
(150mg/kg, i.p) diabetic rats daily for three weeks.
Results: physicochemical parameters complied with the API standards. Phytochemical profiling revealed that the extract contains phenolic 
compounds, flavonoids, glycosides, alkaloids, tannins, and saponins. The extract is rich in phenolic compounds which were 177.33 mg gallic acid 
equivalent/g (GAE/g dry weight) and showed significant percentage inhibition compared to standard ascorbic acid. The extract reduced the fasting 
blood sugar (FBS) level by 46.67–52.67% which is very close to the standard drug glibenclamide (reduced FBS by 65.58%). It also improved the bw 
by 18.20–20.41% after extract treatment where the standard drug increased the bw by 22.95% of the diabetic rats.
Conclusion: In conclusion, Syzygium cumini seed extract is rich in phenolic compounds. Results suggested that the extract possesses significant 
radical (DPPH) scavenging activity and FBS lowering potential in alloxan-induced diabetic rats.
Keywords: Syzygium cumini, Antioxidant activity, Hypoglycemic, Alloxan-induced diabetic rats, Total phenolics, Total flavonoids.
INTRODUCTION
Plants have provided mankind with herbal remedies for many diseases 
for many centuries and even today. Recently, great attention has been 
devoted to the use of natural compounds. India is one of the Nations 
blessed with a rich heritage of traditional medicinal systems [1]. 
When the man is increasing complexities by adding free radicals, 
nature is helping him by supplying immense natural antioxidants 
which inactivate the free radicals and stop unwanted oxidation in the 
body which involve the free radicals formation [2]. The use of herbal 
medicine due to toxicity and side effects of allopathic medicines has led 
to a sudden increase in the number of herbal drug manufacturers. The 
proper authentication of herbal raw materials is critically important to 
the safety and efficacy of herbal medicines. World Health Organization 
(WHO) has emphasized the need to ensure quality control of medicinal 
plant products using modern techniques and by applying suitable 
parameters and standards [3]. Diabetes, the third “killer” of mankind 
after cardiovascular disease and cancer, is affecting nearly 10% of the 
world population [4]. Diabetes mellitus (DM), one of the most common 
endocrine-metabolic disorders is characterized by abnormally high 
blood sugar levels resulting from the body’s inability to produce or 
properly use insulin. Type 2 is characterized by a progressive decline in 
insulin action (insulin resistance, followed by the inability of pancreatic 
β cells to compensate for insulin resistance). In type 2 DM, the function 
of β cells becomes impaired due to insulin resistance leading to 
deterioration in glucose homeostasis and subsequent development of 
impaired glucose tolerance [5]. In diabetes, hyperglycemia generates 
reactive oxygen species (ROS) which, in turn, cause lipid peroxidation 
and membrane damage and thus, causes secondary complications in 
DM such as kidney, eye, blood vessel, and nerve damage [6].
Oral hypoglycemic agents ameliorate the underlying metabolic 
disorders, related to inadequate insulin secretion, insulin resistance, 
and augmented hepatic gluconeogenesis. However, these agents have 
limited efficacy and sometimes produced severe side effects such as 
weight gain, hypoglycemia, liver injury, channel disturbances, and 
cardiopathy. Therefore, there is a need to develop effective, safe and 
cheap drugs for diabetes management. Such effective, safe and cheap 
drugs could be obtained using medicinal plants which have been used 
by humans to prevent or cure diseases including diabetes since the 
dawn of civilization [7]. The use of natural products as antioxidants in 
the management of DM has gained importance throughout the world. 
There has been increasing research focused on natural foods and 
medicinal plants and their phytoconstituents due to their well-known 
abilities to scavenge free radicals. The WHO has also recommended 
and encouraged the use of natural products for the management of 
diabetes and in oxidative stress conditions. Natural antioxidants such 
as flavonoids and polyphenols are believed to possess antioxidant 
properties due to their reducing and chelating capabilities. Natural 
antioxidants can preserve β-cell function by inhibiting the peroxidation 
chain reaction and prevent diabetes-induced ROS formation [8].
Most of the plant parts of Syzygium cumini (L), family Myrtaceae 
(commonly known as Jamun) are documented in the traditional 
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systems of medicine in India as a hypoglycemic in the management of 
diabetes. Therefore, the objective of the present study was to perform 
the pharmacognostical and physicochemical evaluation of S. cumini 
seed powder, phytochemical profiling of ethanolic extract of S. cumini 
seed, determination of total phenolic and flavonoid content and to 




Glibenclamide (Cadila Pharmaceuticals Ltd., Ahmedabad, India), Gallic 
acid, Ascorbic acid (Loba Chemie Pvt Ltd. Mumbai, India), 1, 1-diphenyl-
2-picrylhydrazyl (DPPH) (SRL Pvt. Ltd., Mumbai, India), Quercetin (Herbo 
Nutra, New Delhi, India), and Alloxan monohydrate (Sd Fine Chemicals, 
Mumbai, India), all other chemicals and reagents are of analytical grade.
Instruments
Ultraviolet (UV)-visible spectrophotometer (Thermo Spectronic UV-1, 
Great Britain), pH meter (Digital pH Meter 335, Systronics, Ahmedabad, 
India), Metlar Toledo (AB 204-S, Switzerland), Rotary vacuum 
evaporator (Rolex, India), Centrifuge machine (Remi Equipments Pvt. 
Ltd., Mumbai, India), and glucometer (Accu-chek active blood glucose 
monitoring system) were used.
Plant material
S. cumini seed powder was obtained (Vyas Pharmaceuticals, a GMP 
certified unit, Indore, MP, India).
Morphological evaluation of seed powder
Morphological characteristics of the powdered drug such as color, odor, 
texture, and taste were studied.
Physicochemical evaluation
Moisture content, pH, foreign matter, total ash, acid insoluble ash, 
water soluble ash, water, ethanol, and chloroform-soluble extractive 
values were determined according to the WHO guidelines on quality 
control methods for medicinal plant material and as per the Ayurvedic 
Pharmacopoeia of India (API) [9,10].
Preparation of extract
The S. cumini seed powder was extracted with ethanol: water (70:30) 
at room temperature by maceration for 14 days. The extract was 
then filtered and concentrated by a rotary vacuum evaporator at a 
temperature of 40°C. It was then kept in the refrigerator in an airtight 
container for further studies.
Preliminary phytochemical profiling
The extract was screened for the presence of phenolic compounds, 
flavonoids, tannins, saponins, alkaloids, glycosides, steroids, proteins 
and amino acids, carbohydrates, resins, and triterpenoids using 
various qualitative tests. All tests were performed as per the standard 
procedures [11].
Determination of total phenolic content (TPC)
The TPC of S. cumini seed extract was determined using Folin–Ciocalteu 
reagent method. The intense blue color was developed after incubation. The 
absorbance was measured at 760 nm using UV-visible spectrophotometer 
taking gallic acid as standard (10–60 µg/mL in water). The TPC was 
expressed as mg of gallic acid equivalent (GAE)/g of dw [12-14].
Determination of total flavonoid content (TFC)
Total flavonoid was determined using the aluminum chloride 
colorimetric method on the formation of a complex flavonoid 
aluminum. The developed yellow color indicated the presence 
of flavonoid. The absorbance was measured at 420 nm using a 
UV-visible spectrophotometer. The TFC was calculated using a 
calibration curve for quercetin (10–60 µg/mL in ethanol) as the 
standard. The result was expressed as mg of quercetin equivalent 
(QE)/g dry extract [12,15].
Free radical (DPPH) scavenging activity
The stable DPPH radical was used to assess the free radical 
scavenging potential of the crude ethanolic extract of S. cumini which, 
in turn, determines the in vitro antioxidant activity. The absorbance 
was measured at 517 nm using a UV-visible spectrophotometer. 
Ascorbic acid (50–300 µg/mL in water) was used as reference 
standard. DPPH solution and distilled water served as control and 
blank [16-18].







Ao = Absorbance of the control
At = Absorbance of the sample
Reducing power ability
The reducing power of the extract was investigated by the Fe+3–
Fe+2transformation in the presence of the fractions. The Fe+2 can be 
monitored by measuring the formation of Perl’s Prussian blue at 
700 nm. Ascorbic acid was used as the standard [19,20].
Antidiabetic activity study
Acute toxicity study
The acute oral toxicity study was performed as per the Organization 
for Economic Co-operation and Development (OECD) 423 (acute oral 
toxicity - Acute toxic class method, 2001) guidelines. The limit test was 
employed as the test material is non-toxic as per information gathered. 
For the test, six female Wister albino rats (100–150 g) were selected 
and divided into two each containing three. Normally, females are 
used. This is because literature surveys of conventional LD50 tests show 
that, although there is little difference in sensitivity between the sexes, 
in those cases where differences are observed females are generally 
slightly more sensitive. The rats were kept for at least 5 days in caged 
for laboratory acclimatization before use and fasted (food, but the 
water was not withheld) overnight (12 h). A limit test at one dose level 
of 2000 mg/kg body weight (bw) was given to one group. The animals 
were observed continuously for the first 4h (at least once during the first 
30 min) and for the next 6, 24, and 48h after extract administration and 
daily thereafter, for a total of 14 days. If no death will occur, a limit test at 
one dose level of 5000 mg/kg was given to another group on the 5th day. 
Neurological and behavioral changes were observed for any signs of 
acute toxicity and recorded. All mortality within a period of testing the 
extract was also noted. If test substance-related mortality is produced, 
further testing at the next lower level may need to be carried out [21].
Experimental animals
Wistar albino rats were randomly bred in the Institutional Animal House. 
The animals were maintained under controlled room temperature 
(22±2°C) and humidity (55±5%) with 12:12 h light and dark cycle. All the 
animals were provided with commercially available rat normal pellet diet 
and water ad libitum. The guidelines of the Committee for the Purpose of 
Control and Supervision of Experiments on Animals of the Goverment of 
India were followed, and prior permission and clearance were granted 
from the Institutional Animal Ethics Committee (No. - GCTS/IAEC/2014-
Jan/02) for conducting the animal experimental studies [5].
Induction of diabetes
Wistar albino rats of either sex weighing 100–150 g were selected 
for the study. Diabetes was induced in 12 h fasted rats by a single 
intraperitoneal injection of 150 mg/kg bw of freshly prepared alloxan 
monohydrate in distilled water. After alloxan injection rats were given 
10% w/v glucose solution in feeding bottles for the next 24 h in their 
cages to prevent hypoglycemia. After 72 h rats with fasting blood glucose 
levels >200 mg/dL were selected and used for the study [6,15,22].
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Treatment protocol
The rats were divided into 5 groups, each containing 6 animals. The 
extract of S. cumini seed was given as a suspension in distilled water at 
a dose of 1 mL/kg to different groups of animals [6,15,22].
• Group 1: Negative control (normal rats) received distilled water
• Group 2: Diabetic control received distilled water
• Group 3: Positive control received glibenclamide (10 mg/kg, p.o)
• Group 4: Diabetic rats received extract (200 mg/kg, p.o)
• Group 5: Diabetic rats received extract (400 mg/kg, p.o)
All were administered by oral gavage. The blood glucose levels and the 
weight of the rats were estimated at 0, 7th, 14th, and 21st days with the 
drug and extract being administered daily for 21 days from the day of 
induction. Blood samples were drawn from the tip of the tail, and blood 
glucose level was measured using the glucometer.
Statistical analysis
All the experiments were carried out in triplicates. The values are 
represented as a mean ± standard deviation (SD). Results were analyzed 
using one-way analysis of variance where p<0.05 took as statistically 
significant value.
RESULTS
Morphological evaluation of seed powder
The seed powder is brownish colored with an aromatic odor, bitter 
tasted, and coarse textured.
Physico-chemical evaluation
The results of physico-chemical studies are expressed in Table 1.









Alcohol soluble extractives 87.1%
Water soluble extractives 94.2%
Chloroform-soluble extractives 90.95%
The experiments were performed in triplicate, and the data are 
represented as the mean value.
Preliminary phytochemical profiling
The phytoconstituents present in the extract are given in Table 2.











Proteins and amino acids -
Resins +
Glycosides +
+: Present, -: Absent. S. cumini: Syzygium cumini
The standard curve of gallic acid
 
Fig. 1: Standard curve of gallic acid. Results are expressed as the 
mean value (n=3)
The standard curve of quercetin
Fig. 2: Standard curve of quercetin. Results are expressed as the 
mean value (n=3)
TPC
The TPC of the extract was found to be 177.33±1.15 mg of GAE/g of dry 
extract determined by Folin–Ciocalteu reagent method (Value is given 
as mean ± SD, where n=3).
TFC
The TFC of the extract was found to be 86.33±1.52 mg of QE/g of dry 
extract determined by the aluminum chloride colorimetric method 
(Value is given as mean ± SD, where n=3).
In vitro antioxidant study
Table 3 shows (DPPH radical scavenging activity). Table 4 shows 
(Reducing power ability).
Acute toxicity studies (OECD 423)
No mortality and no signs of toxicity were found at the dose of 
2000 mg/kg and 5000 mg/kg bw. Therefore, it might be considered 
that hydroalcoholic extract of the seeds of S. cumini was safe to use 
below 5000 mg/kg bw. The extract was safely administered at a dose 
of 200 mg and 400 mg per kg bw to the alloxan-induced diabetic rats.
Antidiabetic activity in alloxan-induced diabetic rats
Table 5 shows (Changes in blood glucose level (mg/dL) in groups of normal 
and alloxan-induced diabetic rats (n=6)). Table 6 shows (Changes in body 
weight (g) in groups of normal and alloxan-induced diabetic rats (n=6)).
DISCUSSION
Although hyphenated analytical techniques are available, still 
pharmacognostical and physicochemical parameters study is more 
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Table 5: Changes in blood glucose level (mg/dL) in groups of normal and alloxan-induced diabetic rats (n=6)
Groups Pre-treatment Post-treatment % Reduction
Day 0 Day 7 Day 14 Day 21
Normal control 84.73±3.32 86.05±2.73 86.21±2.68 87.13±4.79 -
Diabetic control 234.75±3.43 257.51±2.40* 271.76±3.83* 278.76±4.81* -
Standard drug-treated 286.07±4.33 190.41±4.20* 126.52±4.28* 98.45±3.50* 65.58
Extract treated 200 mg/kg 221.05±3.05 200.85±2.83* 190.70±4.62* 117.87±3.54* 46.67
Extract treated 400 mg/kg 236.24±2.65 205.13±3.5* 178.81±3.99* 111.80±2.16* 52.67
Values are given as mean±SD (n=6) statistical significance was evaluated by one-way analysis of variance (ANOVA) at *p<0.05. Diabetic control was compared to normal 
control and experimental groups were compared to diabetic control group
Table 6: Changes in body weight (g) in groups of normal and alloxan-induced diabetic rats (n=6)
Groups Before alloxan administration Pre-treatment Post-treatment
Day 0 Day 7 Day 14 Day 21
Normal control 125.33±2.16 125.66±1.80 126.25±1.08 127.25±1.75 126.25±3.76
Diabetic control 121.25±1.12 98.25±1.83* 88.5±1.44* 85.08±2.39* 78.83±3.2*
Standard drug-treated 125±3.17 93.66±1.53* 97.25±1.63* 102.08±1.80* 115.16±1.94*
Extract treated 200 mg/kg 130.58±2.95 91.5±2.02* 94.16±1.36* 97.08±3.36* 108.16±2.13*
Extract treated 400 mg/kg 128.5±1.78 92.66±3.17* 99±2.04* 101.5±2.81* 111.58±1.98*
Values are given as mean±SD (n=6) statistical significance was evaluated by one-way analysis of variance (ANOVA) at *p<0.05. Diabetic control was compared to normal 
control, and experimental groups were compared to diabetic control group
Table 4: Reducing power ability









Values are given as mean ± SD, where n=3
Table 3: DPPH radical scavenging activity











Values are given as mean±SD, where n=3
Folin–Ciocalteu reagent method which is simple, fast, convenient, and 
most importantly reproducible. The findings confirm that the extract is 
rich in phenolic contents (177.33±1.15 mg GAE/g dw).
Flavonoids also act through scavenging and chelating process. 
Flavonoids, which contain hydroxyl groups, are responsible for the 
antioxidant effect of the plant [28]. They are effective scavengers of 
most oxidizing molecules including singlet oxygen and various free 
radicals implicated in several diseases [29]. High flavonoid contents 
present in the extract, i.e. 86.33±1.52 mg QE/g dw.
Free radical scavenging test is relatively straightforward to perform 
in vitro antioxidant activity. Stable DPPH radical scavenging 
method is a rapid, simple, inexpensive, reproducible, and sensitive 
way to survey the antioxidant activity of a specific compound or 
plant extracts in comparison to other models. In the presence of 
a hydrogen donating polyphenols in the extract, purple colored 
stable DPPH is reduced to yellow colored non-radical form DPPH-H 
(diphenylpicrylhydrazine) in a concentration dependent manner. 
The antioxidant effect is proportional to the disappearance of the 
purple color of DPPH in test samples [30-32]. The findings were 
represented in Table 3 as percentage inhibition, and the extract 
showed a fair scavenging activity lower than that of ascorbic acid 
(standard).
The reducing ability of the extract depends on the presence of reductant 
which exerts antioxidant action based on breaking the free radical chain 
by donating hydrogen atom. The reducer causes the conversion of Fe+3/
ferricyanide complex to Fe+2 form which is measured by the formation 
of Perl’s Prussian blue at 700 nm [33]. The reducing power of extract 
was compared with ascorbic acid as standards. All the samples showed 
significant reducing power capacity in a concentration-dependent 
manner, but less than standard. The maximum reduction was observed 
at the concentration of 300 µg/mL. The absorbance for extract was 
1.003 and 1.593 for the standard. From the results obtained in this 
study, it is suggested that the ethanolic extract potentially donates the 
electron to reactive free radicals to convert them into more stable non-
reactive form and terminates the free radical chain reaction [34].
Impaired carbohydrate, fat, and protein metabolism are associated with 
DM, which are of vital public importance as physiological complications 
associated with it [35]. The underlying causes of hyperglycemia in DM 
are overproduction and decreased utilization of glucose by the tissue. 
Most of the diabetic complications are mediated through oxidative 
reliable to identify and evaluate herbal drugs [23]. Physicochemical 
parameters are very much helpful for judging the quality as well 
as purity of drugs [24]. S. cumini seed powder complied all the 
physicochemical standards as per the API and WHO guidelines for 
quality control methods for medicinal plant materials. Preliminary 
qualitative phytochemical analysis revealed the presence of various 
phytoconstituents (Table 2) which are reported to have many biological 
and therapeutic properties [25].
Plant phenolics, as hydrogen donating free radical scavengers, 
have received considerable attention as they are wide-spread plant 
secondary metabolites and also known as sources of potential 
natural antioxidants. They act both as radical scavengers and metal 
chelators [26,27]. TPC in the S. cumini seed extract was estimated by 
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stress. The oxidative stress and resultant tissue damage are important 
components in the pathogenesis of diabetic complications. Diabetes is 
associated with increased formation of free radicals and decreases in 
antioxidant potential. The increase in oxygen free radicals in diabetes 
could be due to increase in blood glucose levels, which on auto-
oxidation generates free radicals [36]. The ROS and related oxidative 
stress are the root cause of developing insulin resistance, impaired 
β-cell function, and type-2 DM. Insulin resistance, which is the reduced 
response of target tissues such as skeletal muscle, liver, and adipocytes 
to insulin, plays a major role in the pathogenesis of type II diabetes. 
Skeletal muscle is the predominant site of insulin-mediated glucose 
uptake in the postprandial state. Normal glucose homeostasis depends 
on a well-balanced interaction between tissue sensitivity to insulin 
and insulin secretion [37]. To combat the diabetic complications, wide 
varieties of synthetic oral hypoglycemic agents are available. However, 
due to their undesirable side effects, there is a need to search for safe 
and effective molecules from nature. Therefore, in the present study, 
the hypoglycemic effect of S. cumini seed extract was investigated in 
alloxan-induced diabetic Wistar rats in comparison with the standard 
antidiabetic drug, glibenclamide (10 mg/kg bw). The preliminary 
studies (acute toxicity study) revealed the non-toxic nature of the 
extract on normal rats. Alloxan has been widely used to induce diabetes 
in a wide variety of animals which causes β-cell cytotoxicity. In this 
study, the difference has been observed in initial and final FBS level 
and bw of different treated groups and significant elevation in blood 
glucose level in the diabetic control group at the end of 21-day study 
period [8,38]. The significant decrease in FBS level was observed after 
continuous treatment with extract for 21 days. The extract reduced the 
glucose level by 46.67% at 200 mg/kg bw and 52.67% at 400 mg/kg 
bw which is very close to the standard drug glibenclamide (65.58% 
reduction). The extract treated group showed significant improvement 
in bw in comparison to diabetic control and glibenclamide treated 
group which is due to controlling muscle wasting (protein loss), i.e. - the 
reversal of gluconeogenesis. Glibenclamide which has been used for 
many years to treat diabetes stimulates insulin secretion from β-cell. 
The possible mechanism of hypoglycemic effect of S. cumini seed may 
be by potentiation of insulin effect [4,6].
CONCLUSION
The outcomes of this study support the traditional use of S. cumini as 
potential therapeutic agents to treat various diseases mainly diabetes. 
Based on the results obtained, it has been concluded that the ethanolic 
extract of the seeds of S. cumini contains secondary metabolites which 
are associated with important biological activities. The extract is rich 
in phenols and flavonoids. It possesses strong antioxidant and blood 
glucose lowering potentials.
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